Literature DB >> 12014888

Cerebral visual impairment in children.

G N Dutton1, L K Jacobson.   

Abstract

Much of the brain is devoted to vision. Damage causes visual problems ranging from profound impairment, to cognitive visual problems only. A child with cerebral blindness may have intact perception of movement. The principal cognitive visual pathways comprise the dorsal and the ventral streams. The dorsal stream runs between the occipital lobes (which process incoming visual data), the posterior parietal lobes (which process the whole visual scene and give attention to component parts), the motor cortex (which facilitates movement through the visual scene) and the frontal cortex (which directs attention to chosen parts of the visual scene). The ventral stream runs between the occipital lobes and the temporal lobes (which enable recognition of people and objects, facilitate route finding and serve visual memory). Damage to these pathways disrupts these functions in a variety of combinations. This paper reviews cerebral visual impairment in children, the differential diagnosis and the management. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 12014888     DOI: 10.1053/siny.2001.0078

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  39 in total

Review 1.  Unravelling the development of the visual cortex: implications for plasticity and repair.

Authors:  James A Bourne
Journal:  J Anat       Date:  2010-08-17       Impact factor: 2.610

2.  Visual problems as a result of brain damage in children.

Authors:  G N Dutton; E C A McKillop; S Saidkasimova
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

3.  Arnold-Chiari Malformation Type III With Meningoencephalocele: A Case Report.

Authors:  Dae Ho Jeong; Chang Hwan Kim; Myeong Ok Kim; Hyung Chung; Tae Hyun Kim; Han Young Jung
Journal:  Ann Rehabil Med       Date:  2014-06-26

4.  A functional approach to cerebral visual impairments in very preterm/very-low-birth-weight children.

Authors:  Christiaan J A Geldof; Aleid G van Wassenaer-Leemhuis; Marjolein Dik; Joke H Kok; Jaap Oosterlaan
Journal:  Pediatr Res       Date:  2015-04-30       Impact factor: 3.756

5.  Novel genetic causes for cerebral visual impairment.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Nicole de Leeuw; Rolph Pfundt; Willy M Nillesen; Joep de Ligt; Christian Gilissen; Shalini Jhangiani; James R Lupski; Frans P M Cremers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

6.  Brain visual impairment in childhood: mini review.

Authors:  N Kozeis
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

7.  Early visual-evoked potential acuity and future behavioral acuity in cortical visual impairment.

Authors:  Tonya Watson; Deborah Orel-Bixler; Gunilla Haegerstrom-Portnoy
Journal:  Optom Vis Sci       Date:  2010-02       Impact factor: 1.973

8.  NR2F1 mutations cause optic atrophy with intellectual disability.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Claudia Gonzaga-Jauregui; Mafei Xu; Joep de Ligt; Shalini Jhangiani; Wojciech Wiszniewski; Donna M Muzny; Helger G Yntema; Rolph Pfundt; Lisenka E L M Vissers; Liesbeth Spruijt; Ellen A W Blokland; Chun-An Chen; Richard A Lewis; Sophia Y Tsai; Richard A Gibbs; Ming-Jer Tsai; James R Lupski; Huda Y Zoghbi; Frans P M Cremers; Bert B A de Vries; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2014-01-23       Impact factor: 11.025

9.  VEP vernier, VEP grating, and behavioral grating acuity in patients with cortical visual impairment.

Authors:  Tonya Watson; Deborah Orel-Bixler; Gunilla Haegerstrom-Portnoy
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

10.  Contributing factors to VEP grating acuity deficit and inter-ocular acuity difference in children with cerebral visual impairment.

Authors:  Nívea Nunes Cavascan; Solange Rios Salomão; Paula Yuri Sacai; Josenilson Martins Pereira; Daniel Martins Rocha; Adriana Berezovsky
Journal:  Doc Ophthalmol       Date:  2013-12-18       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.